Antiplatelet regimens following carotid artery revascularization
- PMID: 35863439
- DOI: 10.1016/j.ahj.2022.07.004
Antiplatelet regimens following carotid artery revascularization
Abstract
Dual antiplatelet therapy (DAPT) is indicated following carotid artery stenting (CAS) and single antiplatelet therapy (SAPT) following carotid endarterectomy (CEA), but it remains unknown how providers adhere to these guidelines in real-world clinical practice. Using the Vascular Quality Initiative New England data, we found that of 12,257 patients, 82% patients were discharged on DAPT following CAS and 66% were discharged on SAPT following CEA. While a high percentage of patients undergoing CAS appropriately receive DAPT, the use of SAPT following CEA exists with more variability and lower adherence rates.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of Interest Dr. Mena-Hurtado is a consultant for Cook Medical, Medtronic, Abbott, Cardinal Health, and Optum Labs. Dr. Smolderen reports grant funding from Abbott, Gore, Johnson&Johnson, Cardiva, and Merck, and she is a consultant for Optum Labs and Abbott. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical